Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol Ophthalmic Solution (Rhone)

This study (called Rhone) is testing the safety and effectiveness of a bimatoprost implant — a small device placed inside the eye that slowly releases glaucoma medication — when used together with a new type of intraocular lens (SpyGlass IOL) during cataract surgery. The Rhone study is a companion to the Rhine study, and both evaluate whether this combination reduces eye pressure better than standard eye drops. **You may be eligible if...** - You have mild to moderate open-angle glaucoma or elevated eye pressure (ocular hypertension) - You are scheduled to have cataract removal surgery - If you are a woman of childbearing age, you are willing to use contraception and have a negative pregnancy test **You may NOT be eligible if...** - You have an uncontrolled systemic (whole-body) disease - You have had previous corneal surgery (such as LASIK or PRK) - Your glaucoma is a type other than open-angle, pseudoexfoliative, or pigmentary glaucoma - You have had previous glaucoma surgery or intraocular injections - You have other significant eye diseases Talk to your doctor to see if this trial is right for you.